Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
55
Number of overlapping holdings
28.6%
% of IBB's 212 holdings also in BBP
90.2%
% of BBP's 65 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.2% | 2.1% | 2.1% |
|
GILEAD SCIENCES INC | 9.9% | 1.8% | 1.8% |
|
AMGEN INC | 6.9% | 1.6% | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.6% | 1.7% | 1.6% |
|
REGENERON PHARMACEUTICALS | 5.3% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to BBP
|
GILEAD SCIENCES INC | 8.1% |
|
VERTEX PHARMACEUTICALS INC | 6.5% |
|
AMGEN INC | 5.3% |
|
REGENERON PHARMACEUTICALS | 3.7% |
|
IQVIA HOLDINGS INC | 3.7% |
 |
ARGENX SE ADR | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
ILLUMINA INC | 2.3% |
|
WATERS CORP | 2.3% |
|
NATERA INC | 2.0% |
IBB Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.2% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
TRAVERE THERAPEUTICS, INC. | -1.8% |
|
TG THERAPEUTICS INC | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.7% |
|
LIGAND PHARMACEUTICALS-CL B | -1.7% |
 |
THERAVANCE BIOPHARMA INC | -1.7% |
|
BIOCRYST PHARMACEUTICALS INC | -1.7% |
|
IRONWOOD PHARMACEUTICALS INC | -1.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |